Zantac Recall: Does Ranitidine Cause Cancer?
Late September 2019, Valisure filed a Citizen Petition urging the FDA to recall ranitidine. Although several drug companies and major drug store chains quickly suspended sales of Zantac and its generic ranitidine voluntarily, the FDA did not issue... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 26, 2019 Category: General Medicine Source Type: news

From Licorice to Slippery Elm: What Works for GI Symptoms? From Licorice to Slippery Elm: What Works for GI Symptoms?
In the wake of recent concerns with ranitidine, Dr David Johnson shares the evidence (or lack thereof) for some popular alternative remedies that patients may turn to for upper GI diseases like reflux.Medscape Gastroenterology (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - November 22, 2019 Category: Gastroenterology Tags: Gastroenterology Commentary Source Type: news

Tanzania: Tanzania Agency Bans Ranitidine-Based Drugs
[East African] The state-run Tanzania Medicines and Medical Devices Authority (TMDA) has suspended the use of medicines containing the active pharmaceutical ingredient Ranitidine until further notice. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 22, 2019 Category: African Health Source Type: news

Class 2 medicines recall: Ranitidine 75mg tablets
OTC Concepts Ltd, Relconchem Ltd and Noumed Life Sciences Ltd are recalling all unexpired batches of the products mentioned in the MHRA alert from pharmacies and retail stores as a precautionary measu (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - November 21, 2019 Category: Drugs & Pharmacology Source Type: news

Tanzania: Tanzania Medicines and Medical Devices Authority Bans Heartburn Medications Over Cancer Risk
[Citizen] Dar es Salaam -All patients taking heartburn drugs with the active ingredient ranitidine must stop their course of treatment and report to a nearby health facility after authorities raised concern about the safety of the drugs. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 21, 2019 Category: African Health Source Type: news

Precision Dose Inc. Issues Voluntary Nationwide Recall of Ranitidine Oral Solution, USP 150 mg/10 mL Due to Possible Presence of N-nitrosodimethylamine (NDMA) Impurity.
Precision Dose Inc. is voluntarily recalling 5 lots of Ranitidine Oral Solution, USP 150 mg/10 mL to the consumer level. Ranitidine Oral Solution, USP 150 mg/10 mL, is being recalled because of potential N-Nitrosodimethylamine (NDMA) amounts above levels established by the FDA. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - November 19, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news